Cognitive-behavioral therapy versus education and desipramine versus placebo for moderate to severe functional bowel disorders

Gastroenterology

Volumn 125, Issue 1, 2003, Pages 19-31

  Drossman, Douglas A ^a   Toner, Brenda B ^c   Whitehead, William E ^a   Diamant, Nicholas E ^d   Dalton, Christine B ^a   Duncan, Susan ^d   Emmott, Shelagh ^c   Proffitt, Valerie ^a   Akman, Donna ^c   Frusciante, Karen ^e   Le, Terry ^a   Meyer, Kim ^a   Bradshaw, Barbara ^a   Mikula, Kristi ^d   Morris, Carolyn B ^a   Blackman, Carlar J ^a   Hu, Yuming ^a   Jia, Huanguang ^a   Li, Jim Z ^f   Koch, Gary G ^a   Bangdiwala, Shrikant I ^b   more..

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b IL   (United States)

^c UNIVERSITY OF TORONTO   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

^e GLAXOSMITHKLINE   (United States)

^f PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DESIPRAMINE; PLACEBO;

ABDOMINAL PAIN; ADULT; ARTICLE; BEHAVIOR THERAPY; CLINICAL TRIAL; COGNITIVE THERAPY; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DISEASE SEVERITY; DROWSINESS; DRUG EFFICACY; DRUG SAFETY; ENTEROPATHY; FATIGUE; FEMALE; FLUSHING; HEADACHE; HEART ARRHYTHMIA; HEARTBURN; HUMAN; INFLUENZA; INTERMETHOD COMPARISON; IRRITABLE COLON; MAJOR CLINICAL STUDY; MULTICENTER STUDY; NAUSEA; NERVOUSNESS; PATIENT EDUCATION; PRIORITY JOURNAL; PSYCHOTHERAPY; RANDOMIZED CONTROLLED TRIAL; RASH; SIDE EFFECT; SLEEP DISORDER; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME; VERTIGO; XEROSTOMIA;

EID: 10744226862     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0016-5085(03)00669-3     Document Type: Article

References (46)

1. Thompson WG, Longstreth GF, Drossman DA, Heaton KW, Irvine EJ, Mueller-Lissner SA. Functional bowel disorders and functional abdominal pain. In: Drossman DA, Talley NJ, Thompson WG, Whitehead WE, Corazziari E, eds. Rome II: functional gastrointestinal disorders: diagnosis, pathophysiology, and treatment. (2nd ed). McLean, VA: Degnon Associates, Inc., 2000:351-432.
2. Sandler RS, Everhart JE, Dorowitz M, Adams E, Cronin K, Goodman C, Gemmen E, Shah S, Avdic A, Rubin R. The burden of selected digestive diseases in the United States. Gastroenterology 2002;122:1500-1511.
3. Drossman DA, Camilleri M, Mayer EA, Whitehead WE. AGA technical review on irritable bowel syndrome. Gastroenterology 2002; 123:2108-2131.
4. Mayer EA, Naliboff BD, Chang L, Coutinho SV. Stress and the gastrointestinal tract v. stress and irritable bowel syndrome. Am J Physiol 2001;280:G519-G524.
5. Drossman DA, Whitehead WE, Toner BB, Diamant NE, Hu YJB, Bangdiwala SI, Jia H. What determines severity among patients with painful functional bowel disorders? Am J Gastroenterol 2000;95:974-980.
6. Clouse RE. Antidepressants for functional gastrointestinal syndromes. Dig Dis Sci 1994;39:2352-2363.
7. Wald A. Psychotropic agents in irritable bowel syndrome. J Clin Gastroenterol 2002;35:S53-S57.
8. Jackson JL, O'Malley PG, Tomkins G, Balden E, Santoro J, Kroenke K. Treatment of functional gastrointestinal disorders with anti-depressants: a meta-analysis. Am J Med 2000;108:65-72.
9. Drossman DA, Creed FH, Olden KW, Svedlund J, Toner BB, Whitehead WE. Psychosocial aspects of the functional gastrointestinal disorders. In: Drossman DA, Corazziari E, Talley NJ, Thompson WG, Whitehead WE, eds. Rome II: functional gastrointestinal disorders: diagnosis, pathophysiology, and treatment. (2nd ed). McLean, VA: Degnon Associates, Inc., 2000:157-245.
10. Drossman DA, Leserman J, Nachman G, Li Z, Gluck H, Toomey TC, Mitchell CM. Sexual and physical abuse in women with functional or organic gastrointestinal disorders. Ann Intern Med 1990;113:828-833.
11. Drossman DA, Li Z, Leserman J, Keefe FJ, Hu YJ, Toomey TC. Effects of coping on health outcome among female patients with gastrointestinal disorders. Psychosom Med 2000;62:309-317.
12. Drossman DA, Li Z, Leserman J, Toomey TC, Hu Y. Health status by gastrointestinal diagnosis and abuse history. Gastroenterology 1996;110:999-1007.
13. Melzack R. The McGill Pain Questionnaire: major properties and scoring methods. Pain 1975;1:277-299.
14. Heaton KW, Gosh S. Relation between stool form on a seven point scale and symptoms of urgency, straining, and incomplete evacuation: a new way of looking at irritable bowel syndrome. Gut 1989;30:A1465 Abstract.
15. Drossman DA, Li Z, Toner BB, Diamant NE, Creed FH, Thompson DG, Read NW, Babbs C, Barreiro M, Bank L, Whitehead WE, Schuster MM, Guthrie EA. Functional bowel disorders: a multicenter comparison of health status, and development of illness severity index. Dig Dis Sci 1995;40:986-995.
16. Drossman DA, Richter JE, Talley NJ, Thompson WG, Corazziari E, Whitehead WE. The functional gastrointestinal disorders: diagnosis, pathophysiology, and treatment. 1st ed. McLean, VA: Degnon Associates, Inc., 1994.
17. Diamant NE, Kamm MA, Wald A, Whitehead WE. American Gastroenterological Association medical position statement on anorectal testing techniques. Gastroenterology 1999;116:732-735.
18. Whitehead WE, Drossman DA, Diamant N, Toner BB, Bangdiwala SI, Hu Y, Bradshaw B, Leutri F, Mikula K, Jia H. Correlation of changes in clinical pain and abnormal stools with changes in visceral pain thresholds following treatment (abstr). Gastroenterology 2000;118(Suppl 2):A128.
19. Beck AT, Rush AJ, Shaw BF, Emery G. Cognitive therapy of depression: a treatment manual. New York: Guilford, 1979.
20. Toner BB, Segal ZV, Emmott SD, Myran D. Cognitive-behavioral treatment of irritable bowel syndrome: the brain-gut connection. New York: Guilford, 2000.
21. Thompson WG. Gut reactions, New York: Plenum, 1989.
22. Borkovec TD, Nau SD. Credibility of analogue therapy rationales. J Behav Ther Exp Psychiatry 1972;3:257-260.
23. Tichenor V, Hill CE. A comparison of six measures of working alliance. Psychotherapy 1989;26:195-199.
24. Toner BB, Stuckless N, Ali A, Downie FP, Emmott SD, Akman DE. The development of a cognitive scale for functional bowel disorders. Psychosom Med 1998;60:492-497.
25. Toner BB, Segal ZV, Emmott S, Myran D, Ali A, DiGasbarro I, Stuckless N. Cognitive behavior group therapy for patients with irritable bowel syndrome. Int J Group Psychother 1998;48:215-243.
26. Patrick DL, Drossman DA, Frederick IO, DiCesare J, Puder KL. Quality of life in persons with irritable bowel syndrome: development of a new measure. Dig Dis Sci 1998;43:400-411.
27. Drossman DA, Patrick DL, Whitehead WE, Toner BB, Diamant NE, Hu YJB, Jia H, Bangdiwala SI. Further validation of the IBS-QOL: a disease specific quality of life questionnaire. Am J Gastoenterol 2000;95:999-1007.
28. Veldhuyzen van Zanten SJO, Talley NJ, Bytzer P, Klein K, Whorwell PJ, Zinsmeister AR. Design of treatment trials for the functional gastrointestinal disorders. In: Drossman DA, Corazziari E, Talley NJ, Thompson WG, Whitehead WE, eds. Rome II: functional gastrointestinal disorders: diagnosis, pathophysiology, and treatment (2nd ed). McLean, VA: Degnon Associates, Inc., 2000: 577-622.
29. McQuay HJ, Moore RA. Using numerical results from systematic reviews in clinical practice. Ann Intern Med 1997;126:712-720.
30. Bauer P. Multiple testing in clinical trials. Stat Med 1992;10: 871-890.
31. O'Brien P. Procedures for comparing samples with multiple endpoints. Biometrics 1984;40:1079-1087.
32. Lachin J. Some large-sample distribution-free estimators and tests for multivariate, partially incomplete data from two populations. Stat Med 1992;11:1151-1170.
33. Designing clinical research, Baltimore: Williams and Wilkins, 1988.
34. Schell MJ, McBride R, Gennings C, Koch GG. The intention-to-treat principle for clinical trials. In: Guiloff RJ, ed. Clinical trials in neurology. London: Springer-Verlag, 2001:131-144.
35. Whitehead WE, Corrazziari E, Prizont R, Senior JR, Thompson WG, Veldhuyzen van Zanten SJO. Definition of a responder in clinical trials for functional gastrointestinal disorders. In: Drossman DA, Corazziari E, Talley NJ, Thompson WG, Whitehead WE, eds. Rome II: functional gastrointestinal disorders: diagnosis, pathophysiology, and treatment. 2nd ed. McLean, VA: Degnon Associates, Inc., 2000:623-627.
36. Drossman DA. Do psychosocial factors define symptom severity and patient status? Am J Med 1999;107:41S-50S.
37. Guthrie E, Creed F, Dawson D, Tomenson B. A controlled trial of psychological treatment for the irritable bowel syndrome. Gastroenterology 1991;100:450-457.
38. Whorwell PJ, Prior A, Colgan SM. Hypnotherapy in severe irritable bowel syndrome: further experience. Gut 1987;28:423-425.
39. Drossman DA. Psychosocial sound bites: exercises in the patient-doctor relationship. Am J Gastroenterol 1997;92:1418-1423.
40. Hirschfeld RM, Dunner DL, Keitner G, Klein DN, Koran LM, Kornstein SG, Markowitz JC, Miller I, Nemeroff CB, Ninan PT, Rush AJ, Schatzberg AF, Thase ME, Trivedi MH, Borian FE, Crits-Christoph P, Keller MB. Does psychosocial functioning improve independent of depressive symptoms? A comparison of nefazodone, psychotherapy, and their combination. Biol Psychiatry 2002;51: 123-133.
41. Holroyd KA, O'Donnell FJ, Stensland J, Lipchik GL, Cordingley GE, Carlson BW. Management of chronic tension-type headache with tricyclic antidepressant medication, stress management therapy, and their combination. JAMA 2001;285:2208-2215.
42. Thompson LW, Coon DW, Gallagher-Thompson D, Sommer BR, Koin D. Comparison of desipramine and cognitive/behavioral therapy in the treatment of elderly outpatients with mild-to-moderate depression. Am J Geriatr Psychiatry 2001;9:225-240.
43. Segal Z, Vincent P, Levitt A. Efficacy of combined, sequential and crossover psychotherapy and pharmacotherapy in improving outcomes in depression. J Psychiatry Neurosci 2002;27:281-290.
44. Greenbaum DS, Mayle JE, Vanegeren LE, Jerome JA, Mayor JW, Greenbaum RB, Matson RW, Stein GE, Dean HA, Halvorsen NA, Rosen LW. The effects of desipramine on IBS compared with atropine and placebo. Dig Dis Sci 1987;32:257-266.
45. Fishbain DA, Cutler RB, Rosomoff HL, Rosomoff RS. Do antidepressants have an analgesic effect in psychogenic pain and somatoform pain disorder? A meta-analysis. Psychosom Med 1998;60:503-509.
46. Onghena P, Houdenhove BV. Antidepressant-induced analgesia in chronic non-malignant pain: a meta-analysis of 39 placebo-controlled studies. Pain 1992;49:205-219.